Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1271-1276

  Tenser, Richard B ^a,b   Gaydos, Andrew ^a   Hay, Kathleen A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Division of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE; THYMIDINE KINASE;

ARTICLE; ENZYME ACTIVATION; HERPES SIMPLEX VIRUS; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; SENSORY GANGLION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0030061155     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1271-1276.1996     Document Type: Article

References (47)

1. Arnér, E. S. J., T. Spasokoukotskaja, and S. Eriksson. 1992. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys Res. Commun. 188:712-718.
2. Arnér, E. S. J., A. Valentin, and S. Eriksson. 1992 Thymidme and 3′-azido-3′-deoxthymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways. J. Biol. Chem. 267:10968-10975.
3. Belt, J. A., N. M. Marina, D. A. Phelps, and C. R. Crawford. 1993. Nucleoside transport in normal and neoplastic cells. Adv. Enzyme Regul. 33:235-252.
4. Bloom, D. C., G. B. Devi-Rao, J. M. Hill, J. G. Stevens, and E. K. Wagner. 1994. Molecular analysis of herpes simplex virus type I during epinephrine-induced reactivation of latently infected rabbits in vivo J Virol. 68:1283-1292.
5. Blumenreich, M. S., T. M. Woodcock, M. Andreeff, W. Hiddemann, T. C. Chou, K. Vale, M. O'Hehir, B. D. Clarkson, and C. W. Young. 1984 Effect of very high-dose thymidine infusions on leukemia and lymphoma patients Cancer Res. 44:2203-2207.
6. Coen, D. M. 1992. Molecular aspects of anti-herpesvirus drugs. Semin Virol. 3:3-12.
7. Coen, D. M., N. E. Fleming, Jr., L. K. Leslie, and M. J. Retondo. 1985. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol. 53:477-488.
8. Coen, D. M., M. Kosz-Vnenchak, J. G. Jacobson, D. A. Leib, C. L. Bogard, P. A. Schaffer, K. L. Tyler, and D. M. Knipe. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736-4740.
9. Cooper, G. M. 1973. Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus. Proc. Natl. Acad. Sci USA 70:3788-3792.
10. Crawford, C. R., C. Y. Ng, L. D. Noel, and J. A. Belt. 1990. Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters. J. Biol. Chem. 265:9732-9736
11. Derse, D., Y. C. Cheng, P. A. Furman, M. H. St. Clair, and A. B. Elion. 1981. Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl) guanine triphosphate. Effects on primer-template function J. Biol. Chem. 256:11447-11451.
12. Efstathiou, S., S. Kemp, G. Darby, and A. C. Minson. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathosenesis. J. Gen. Virol. 70:869-879.
13. Eriksson, S., E. Arnér, T. Spasokoukotskaja, L. Wang, A. Karlsson, O. Brosjo, P. Gunven, G. Julusson, and J. Liliemark. 1994. Properties and levels of deoxynucleoside kinases in normal and tumor cells, implications for chemotherapy. Adv Enzyme Regul. 34:13-25.
14. Fife, K. H., C. S. Crumpacker, G. J. Mertz, E. L. Hill, and G. S. Boone. 1994. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. J Infect. Dis. 169:1338-1341.
15. Frost, G. H., K. Rhee, and E. A. Thompson, Jr. 1993 Glucocorticoid regulation of thymidine kinase (Tk-1) expression in L929 cells. J. Biol. Chem. 268:6748-6754.
16. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986 Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase Proc Natl. Acad. Sci. USA 83:8333-8337
17. Gross, M. K., M. S. Kainz, and G. F. Merrill. 1987. The chicken thymidine kinase gene is transcriptionally repressed during terminal differentiation: the associated decline in TK mRNA cannot account fully for the disappearance of TK enzyme activity. Dev. Biol. 122:439-451.
18. Hengstschláger, M., M. Knófler, E. W. Mullner, E. Ogris, E. Wintersberger, and E. Wawra. 1994. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J. Biol. Chem. 269:13836-13842.
19. Hwang, C. B. C., B. Horsburgh, E. Pelosi, S. Roberts, P. Digard, and D. M. Coen. 1994 A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sci. USA 91:5461-5465.
20. Jacobson, J., M. Kramer, F. Rozenberg, A. Hu, and D. M. Coen. 1995. Synergistic effects on ganglionic herpes simplex virus infections by mutations or drugs that inhibit the viral polymerase and thymidine kinase Virology 206:263-268.
21. Jacobson, J. G., K. L. Ruffner, M. Kosz-Vnenchak, C. B. Hwang, K. K. Wobbe, D. M. Knipe, and D. M. Coen. 1993. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Virol 67:6903-6908.
22. Jamieson, A. T., G. A. Gentry, and J. H. Subak-Sharpe. 1974. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses J. Gen. Virol. 24:465-480.
23. Kosz-Vnenchak, M., J. Jacobson, D. M. Coen, and D. M. Knipe. 1993. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67:5383-5393.
24. Larder, B. A. 1993 Inhibition of HIV reverse transcriptase by antiviral agents and drug resistance, p 205-222. In A. M. Skalka and S. P. Goff (ed), Reverse transcriptase. Cold Spring Harbor Laboratory. Cold Spring Harbor. N.Y.
25. Leist, T. P., R. M. Sandri-Goldin, and J. G. Stevens. 1989. Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus. J. Virol. 63:4976-1978
26. Lockshin, A., J. T. Mendoza, B. C. Giovanella, and J. S. Stehlin. Jr. 1984. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells Cancer Res. 44:2534-2539.
27. Lowy, I., M. Caruso, S. P. Goff, and D. Klatzmann. 1994. Cellular thymidine kinase activity is required for the inhibition of HIV-1 replication by AZT in lymphocytes. Virology 200:271-275.
28. Margolis, T. P., F. Sedarati, A. T. Dobson, L. T. Feldman, and J. G. Stevens. 1992. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189:150-160.
29. Medina, D. J., P. P. Tung, M. B. Lerner-Tung, C. J. Nelson, J. W. Mellors, and A. K. Strair. 1995. Sanctuary growth of human immunodeficiency virus in the presence of 3′-azido-3′-deoxythymidine. J. Virol. 69:1606-1611.
30. Meignier, B., R. Longnecker, and B. Roizman. 1988. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J. Infect Dis. 158:602-614.
31. Mertz, G. J., C. C. Jones, J. Mills, K. H. Fife, S. M. Lemon, J. T. Stapleton, E. L. Hill, and L. G. Davis. 1988. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 260:201-206
32. Meyerhans, A., J. P. Vartanian, C. Hultgren, U. Plikat, A. Karlsson, L. Wang, S. Eriksson, and S. Wain-Hobson. 1994. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68:535-540.
33. Perach, M., T. Rubinek, and A. Hizi. 1995. Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase. J Virol. 69:509-512.
34. Plagemann, P. G. W., R. M. Wohlhueter, and C. Woffendin. 1988. Nucleoside and nucleobase transport in animal cells Biochim. Biophys. Acta 947:405-443
35. Sawtell, N. M., and R. L. Thompson. 1992 Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol. 66:2157-2169.
36. Slobedman, B., S. Efstathiou, and A. Simmons. 1994 Quantitative analysis of herpes simplex virus DNA and transcriptional activity in ganglia of mice latently infected with wild-type and thymidine kinase-deficient viral strains. J. Gen. Virol 75:2469-2474
37. Snoeck, R., G. Andrei, J. Balzarini, D. Reymsen, and E. de Clercq. 1994 Dipyridamole potentiates the activity of various acyclic nucleoside phosphonates against varicella-zoster virus, herpes simplex virus and human cytomegalovirus, Antivir. Chem. Chemother. 5:312-321.
38. Spivack, J. G., M. U. Fareed, T. Valyi-Nagy, T. C. Nash, J. S. O'Keefe, R. M. Gesser, E. A. McKie, A. R. MacLean, N. W. Fraser, and S. M. Brown. 1995. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model. J. Gen. Virol. 76:321-332.
39. Straus, S. E., K. D. Croen, M. H. Sawyer, A. G. Freifeld, J. M. Felser, J. K. Dale, H. A. Smith, C. Hallahan, and S. N. Lehrman. 1988 Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment, JAMA 260:2227-2230.
40. Tenser, R. B. 1994. The role of herpes simplex virus thymidme kinase expression in pathogenesis and latency, p. 68-86. In Y. Becker and G Darai (ed.), Pathogenicity of human herpesviruses due to specific pathogenicity genes. Springer-Verlag, Berlin.
41. Tenser, R. B., W. A. Edris, A. Gaydos, and K. A. Hay. 1994. Secondary herpes simplex virus latent infection in transplanted ganglia. J. Virol. 68:7212-7220
42. Tenser, R. B., K. A. Hay, and W. A. Edris. 1989. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidme kinase-negative mutants of herpes simplex virus type 1. J. Virol. 63:2861-2865.
43. Tenser, R. B., J. C. Jones, S. J. Ressel, and F. A. Fralish. 1983. Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses. J. Clin. Microbiol. 17:122-127.
44. Trousdale, M. D., I. Steiner, J. G. Spivak, S. L. Deshame, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1991. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J. Virol. 65:6989-6993.
45. Tung, P. P., and W. C. Summers. 1994. Substrate specificity of Epstein-Barr virus thymidine kinase. Antimicrob. Agents Chemother. 38:2175-2179.
46. Wilcox, C. L., L. S. Crnic, and L. I. Pizer. 1992. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant. Virology 187:348-352.
47. Xu, Y. Z., and W. Plunkett. 1993. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells. J. Biol Chem 268:22363-22368